A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

The committee reviewed recent developments in bilateral labour relations between the two countries, including measures to enhance cooperation in regulating labour recruitment processes and ...

That said, the administration is still absolutely fixated on bilateral trade deficits – that they inherently represent a deadweight loss (despite U.S. companies and households receiving goods and ...

The release said that the LAMAT team worked closely with GPHC’s Department of Ophthalmology, with a special focus on supporting the evolving Vitreo-Retinal Surgical Services.

During these calls, ways to develop bilateral relations and enhance joint coordination on issues of common interest were explored . During the call, Mr. al-Shaibani and his Azerbaijani counterpart ...

YESAFILI is intended for the treatment of neovascular (wet AMD) age-related macular degeneration, visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central ...

The most commonly reported ocular features of infection include: linearly arranged or scattered chorioretinal lesions, anterior uveitis, retinal vasculitis, optic neuritis and vitritis.

India remains hopeful of closing negotiations of the proposed bilateral trade agreement with the US “as quickly as possible” and is stepping up efforts to close free trade agreements with ...

“The visit will provide an opportunity for both sides to review the progress in bilateral relations and the implementation of the outcomes of the India-US joint statement,” the ministry said.

Compr Ophthalmol Update. 2007;8(1):39-49. Disclosure: Dr. Balcer has served as a consultant for development of visual outcomes for trials for Biogen Idec, Merck Serono, Sirtris Pharmaceuticals ...